Neurizon Therapeutics LTD.
from OTCQB Podcast Hosted by OTC Markets Group
Neurizon Therapeutics LTD. (OTCQB: NUZTF) is an Australian clinical-stage biotech company focused on developing treatments for neurodegenerative diseases, with their lead program aimed at ALS. Michael Thurn, CEO and Managing Director of Neurizon, joins us to discuss their mission to address neurodegenerative diseases through its lead ALS therapy View Podcast Transcript
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of OTCQB Podcast?
This episode is 10 minutes long.
When was this OTCQB Podcast episode published?
This episode was published on February 9, 2026.
Can I download this OTCQB Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.